BerandaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$27,14
Setelah Jam Perdagangan Normal:(0,00%)0,00
$27,14
Tutup: 16 Apr, 16.02.32 GMT-4 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$27,82
Rentang hari
$26,87 - $27,74
Rentang tahun
$23,42 - $62,58
Kapitalisasi pasar
1,56Â M USD
Volume Rata-Rata
704,96Â rb
Rasio P/E
2,33
Hasil dividen
-
Bursa utama
NASDAQ
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 10,73Â jt | 51,06% |
Biaya operasional | 51,70Â jt | 46,43% |
Laba bersih | -96,52Â jt | -0,61% |
Margin laba bersih | -899,56 | 33,40% |
Penghasilan per saham | -1,74 | -1,16% |
EBITDA | -123,67Â jt | -17,92% |
Tarif pajak efektif | 8,42% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 893,71Â jt | 15,03% |
Total aset | 1,66Â M | 77,48% |
Total liabilitas | 122,24Â jt | -3,06% |
Total ekuitas | 1,54 M | — |
Saham yang beredar | 57,30 jt | — |
Harga terhadap nilai buku | 1,03 | — |
Tingkat pengembalian aset | -18,09% | — |
Tingkat pengembalian modal | -19,03% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -96,52Â jt | -0,61% |
Kas dari operasi | -133,17Â jt | -83,71% |
Kas dari investasi | -49,16Â jt | -151,47% |
Kas dari pembiayaan | 4,84Â jt | 471,66% |
Perubahan kas bersih | -177,48Â jt | -843,48% |
Arus kas bebas | -108,06Â jt | -155,48% |
Tentang
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Didirikan
2008
Situs
Karyawan
487
